TASK ORDER TITLE: PREVENTING LUNG ADENOCARCINOMA (LUAD) USING TRAIL INDUCING AGENT, ONC201 BASE CONTRACT TI…
Research this with AI
Research smarter with AI
Analyze opportunities and compare insights across leading AI models.
Department of Health and Human Services · UNIVERSITY OF OKLAHOMA
Ask AI researches this public topic. CaptureIQ qualifies the opportunity, manages the pursuit, and prepares review-ready materials.
Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.
Award details
- Award ID
- 75N91022F00003
- Contractor
- UNIVERSITY OF OKLAHOMA
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- National Institutes of Health
- Award amount
- $982,258
- Period of performance
- Sep 8, 2022 – Aug 7, 2027
Public award description
TASK ORDER TITLE: PREVENTING LUNG ADENOCARCINOMA (LUAD) USING TRAIL INDUCING AGENT, ONC201 BASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS
Related intelligence
- Contractor: UNIVERSITY OF OKLAHOMA
- Agency: Department of Health and Human Services
- Federal market intelligence software
Related Federal Awards
- · 75N91022F00002 — TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,435,788
- · 75N91025F00001 — BASE IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE… · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,234,179
- · 75N92023F00001 — STRONG HEART STUDY (SHS)- OKLAHOMA UNIVERSITY HEALTH CENTER (OUHSC) COORDINATING CENTER(CC) SUBTASK B.2 - P… · DEFINITIVE LOGIC CORPORATION · Department of Health and Human Services · $1,218,378
- · 75N91022F00004 — CHEMOPREVENTION WITH MITOCHONDRIA-TARGETED HONOKIOL IN MOUSE MODELS OF LUNG CANCER: ADENOCARCINOMA AND SQUA… · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,201,554
- · 75N91026F00001 — TRIPLE NEGATIVE BREAST CANCER VACCINES · Department of Health and Human Services · $1,147,754
- · 75N91023F00001 — BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BI… · MEDIDATA SOLUTIONS, INC. · Department of Health and Human Services · $1,140,397
Recompete monitoring
Awards approaching a documented period-of-performance end date. Related forecasts or opportunities are linked only when explicit references or strong deterministic signals match — expiration alone is not a confirmed recompete.
- Period ends
- Aug 7, 2027 (288 days)
- Evidence status
- FORECAST IDENTIFIED
- Evidence score
- 50 (deterministic, not pWin)
- Forecast evidence
- Matched forecast
Supporting evidence
- FACT: Award period end date — 2027-08-07
- FACT: Award start date — 2022-09-08
- DERIVED: Days until period end — 288
- FACT: Award recipient (incumbent on this award) — UNIVERSITY OF OKLAHOMA
- FACT: Awarding agency — Department of Health and Human Services
- FACT: Award amount (obligated/total as stored) — 982258